Evaluation of cochlear involvement by transient evoked otoacoustic emission test in children with Crimean-Congo hemorrhagic fever

International Journal of Pediatric Otorhinolaryngology

Volumn 75, Issue 6, 2011, Pages 858-860

  Uysal, Ismail Önder ^a   Kaya, Ali ^a   Güven, Ahmet Sami ^a   Altuntaş, Emine Elif ^a   Müderris, Suphi ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cochlear hearing loss; Crimean Congo hemorrhagic fever; Transient evoked otoacoustic emission (TEOAE)

Indexed keywords

ACOUSTIC REFLEX; ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; COCHLEA INJURY; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; FEMALE; HUMAN; MALE; OTOACOUSTIC EMISSION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PURE TONE AUDIOMETRY; SCHOOL CHILD; TRANSIENT EVOKED OTOACOUSTIC EMISSION; TYMPANOMETRY;

ADOLESCENT; AGE FACTORS; AUDIOMETRY, EVOKED RESPONSE; AUDIOMETRY, PURE-TONE; CASE-CONTROL STUDIES; CHILD; COCHLEA; COHORT STUDIES; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS;

EID: 79955730234     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2011.03.027     Document Type: Article

References (26)

1. Charrel R.N., Attoui H., Butenko A.M., Clegg C.J., Deubel V., Frolova T.V., et al. Tick-borne virus diseases of human interest in Europe. Clin. Microbiol. Infect. 2005, 11:424-426.
2. Bakir M., Ugurlu M., Dokuzoguz B., Bodur H., Tasyaran M.A., Vahaboglu H., Turkish CCHF Study Group Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J. Med. Microbiol. 2005, 54:385-389.
3. Burt F.J., Leman P.A., Smith J.F., Swanepoel R. The use of a reverse transcription-polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean-Congo haemorrhagic fever. J. Virol Methods 1998, 70(2):129-137.
4. Centers for Disease Control and Prevention (CDC) Viral hemorrhagic fever: initial management of suspected and confirmed cases. MMWR Morb. Mortal Wkly. Rep. 1983, 32:27-38.
5. Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004, 64:145-160.
6. Kemp D.T. Stimulated acoustic emissions from within the human auditory system. J. Acoust. Soc. Am. 1978, 64:1386-1391.
7. Kemp D.T. Otoacoustic emissions: their origin in cochlear function, and use. Br. Med. Bull. 2002, 63:223-241.
8. Lonsbury-Martin B.L., Martin G.K. Otoacoustic emissions. Curr. Opin. Otolaryngol. Head Neck Surg. 2003, 11:361-366.
9. Probst R., Lonsbury-Martin B.L., Martin G.K. A review of otoacoustic emissions. J. Acoust. Soc. Am. 1991, 89:2027-2067.
10. Guidelines for screening for hearing impairment and middle ear disorders. Working Group on Acoustic Immittance Measurements and the Committee on Audiologic Evaluation. ASHA 1990, (Suppl. 2):17-24.
11. World Health Organization Crimean-Congo haemorrhagic fever 2010, Fact sheet No. 208, revised November 2001. Available at: http://www.who.int/mediacentre/factsheets/fs208/en/ (accessed July).
12. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect. Dis. 2006, 6:203-214.
13. Simon M., Falk K.I., Lundkvist A., Mirazimi A. Exogenous nitric oxide inhibits Crimean-Congo hemorrhagic fever virus. Virus Res. 2006, 120:184-190.
14. Ergonul O., Zeller H., Celikbas A., Dokuzoguz B. The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region. Int. J. Infect Dis. 2007, 11:48-51.
15. Ergonul O., Celikbas A., Dokuzoguz B., Eren S., Baykam N., Esener H. The characteristics of Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and the impact of oral ribavirin therapy. Clin. Infect. Dis. 2004, 39:284-287.
16. Karti S.S., Odabasi Z., Korten V., Yilmaz M., Sonmez M., Caylan R., et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg. Infect Dis. 2004, 10:1379-1384.
17. Tezer H., Sucakli I.A., Sayli T.R., Celikel E., Yakut I., Kara A., Tunc B., Ergonul O. Crimean-Congo hemorrhagic fever in children. J. Clin. Virol. 2010, 48:184-186.
18. Ergonul O. Clinical and pathologic features of Crimean Congo hemorrhagic fever. Crimean Congo Hemorrhagic Fever: A Global Perspective 2007, 207-220. Springer, Dordrecht, NL. O. Ergonul, C.A. Whitehouse (Eds.).
19. Buchman C.A., Levine J.D., Balkany T.J. Infections of the ear. Essential Otolaryngology, Head & Neck Surgery 2003, 462-511. McGraw-Hill Medical Publishing Division, New York. K.J. Lee (Ed.).
20. Schnittler H.J., Feldmann H. Viral hemorrhagic fever-a vascular disease?. Thromb. Haemost. 2003, 89:967-972.
21. Burt F.J., Swanepoel R., Shieh W.J., Smith J.F., Leman P.A., Greer P.W., et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med. 1997, 121:839-846.
22. Geisbert T.W., Jahrling P.B. Exotic emerging viral diseases: progress and challenges. Nat. Med. 2004, 10:110-121.
23. Bodur H., Akinci E., Ongürü P., Uyar Y., Baştürk B., Gözel M.G., Kayaaslan B.U. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 2010, 14:704-707.
24. Glattke T.J., Robinette M.S. Transient evoked otoacoustic emissions. Otoacoustic Emissions-Clinical Applications 2002, 95-115. Thieme, New York. 2nd edn. R.M. Robinette, T. Glattke (Eds.).
25. Harris F.P., Probst R. Otoacoustic emissions and audiometric outcomes. Otoacoustic Emissions-Clinical Applications 2002, 213-242. Thieme, New York. 2nd edn. R.M. Robinette, T. Glattke (Eds.).
26. Engin A., Yildirim A., Kunt T., Bakir M., Dokmetas I., Ozdemir L. Clinical investigation of the transient evoked otoacoustic emission test in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 2008, 12:162-165.